Evidence map›Paper›PMID 41326714›Full record

ReviewEMBO molecular medicine2026

Artificial intelligence-enabled electrocardiography from scientific research to clinical application.

Chin-Sheng Lin, Wei-Ting Liu, Yuan-Hao Chen, Shih-Hua Lin, Chin Lin

Abstract readReview
In one paragraph

Review in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chin-Sheng LinDivision of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC.ORCID 0000-0002-5167-8327
Wei-Ting LiuDivision of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC.ORCID 0000-0002-3817-4079
Yuan-Hao ChenDepartment of Neurological Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC.
Shih-Hua LinDivision of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC.
Chin LinMedical Technology Education Center, School of Medicine, College of Medicine, National Defense Medical University, Taipei, Taiwan, ROC. xup6fup@mail.ndmctsgh.edu.tw.ORCID 0000-0003-2337-2096

Funding

National Science and Technology Council (NSTC) NSTC 114-2321-B-016-005
6 · The paper itself

Abstract

Recent advancements in artificial intelligence (AI) have revolutionized the application of electrocardiography (ECG) in cardiovascular diagnostics. This review highlights the transformative impact of AI on traditional ECG analysis, detailing how deep learning algorithms are overcoming the limitations of human interpretation and conventional diagnostic criteria. Historically, ECG interpretation has relied on well-established, physiologically-based criteria. The advancement of AI-ECG is marked by its capacity to process complex high-dimensional data directly from raw signals, revealing patterns often missed by conventional methods. Notably, AI models have identified signs of asymptomatic low ejection fraction and paroxysmal atrial fibrillation during normal sinus rhythm, enabling earlier clinical intervention. In addition to improved diagnostic utility, AI-ECG offers promising applications in risk stratification and community screening. Several randomized controlled trials (RCTs) have shown that integrating AI into clinical workflows not only reduces critical intervention times but also identifies patients at elevated risk of adverse outcomes. Future directions involve integrating additional clinical data sources, improving model interpretability through explainable AI, and developing unified platforms to manage outputs from multiple models.

Indexed as

Artificial IntelligenceCardiovascular DiseasesElectrocardiographyAtrial FibrillationDeep LearningHumansArtificial IntelligenceDigital BiomarkerElectrocardiographyOpportunistic ScreeningParadigm Shift

Identifiers

PMID41326714
PMCPMC12808761

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.